Protocol for a health technology assessment of COVID-19 vaccination in Ireland
Record ID 32018015489
English
Authors' objectives:
COVID-19 is caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus that infects the lungs and upper airways. In healthy individuals, infection with SARS-CoV-2 can usually be managed without needing to see a doctor. However, COVID-19 can cause more severe infections in some people which may lead to them being hospitalised or dying. Groups vulnerable to serious complications include older adults, those with underlying medical conditions and those living with immunocompromise.
The Department of Health requested that HIQA complete a health technology assessment (HTA) of various COVID-19 vaccination strategies to inform a decision on COVID-19 vaccination policy in Ireland. This protocol presents the methods for estimating the burden of disease associated with COVID-19 in Ireland, and assessing the economic implications associated with various COVID-19 vaccination strategies in Ireland.
Details
Project Status:
Ongoing
Anticipated Publish Date:
2026
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Ireland
MeSH Terms
- COVID-19 Vaccines
- COVID-19
- SARS-CoV-2
- Vaccination
- Vaccination Coverage
- Mass Vaccination
Keywords
- COVID-19
- Vaccination
Contact
Organisation Name:
Health Information and Quality Authority (HIQA)
Contact Address:
Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name:
info@hiqa.ie
Contact Email:
info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.